… for patients with locally advanced squamous cell carcinoma … chemotherapy to radiotherapy
(chemoradiotherapy, CRT, or … overall survival in some groups of patients. However, CRT is …

… T-cell responses against six cancer-testis antigens in peripheral blood lymphocytes from
patients with esophageal squamous cell carcinoma (… chemoradiotherapy in relation to patients …

… Patients with stage III/IV resectable head and neck squamous cell carcinoma were randomized
to surgery followed by RT or CCRT. The trial was halted prematurely due to poor accrual. …

… This systematic review evaluates the use of postoperative chemoradiotherapy for patients
with advanced (stage III or IV) squamous cell carcinoma of the head and neck at a high risk of …

… patients with locally advanced squamous-cell carcinoma of the head and neck, the proportion
of patients … was 61% (47–72) for in the chemoradiotherapy group and 51% (40–62) in the …

… squamous cell carcinoma who refuse surgical resection and in locally advanced unresectable
esophageal squamous cell carcinoma patients. Concurrent chemoradiotherapy prolongs …

Background & Aims Surgery is the standard of care for T1bN0M0 esophageal squamous
cell carcinoma (ESCC), whereas chemoradiotherapy (CRT) is a treatment option. This trial …

… , none of the patients enrolled in this study had oesophageal adenocarcinoma; thus, all
patients had squamous cell carcinoma of the oesophagus. All patients were enrolled in the …

… for esophageal cancer is chemoradiotherapy (CRT) in addition to surgical resection[3].
Preoperative CRT had been applied to patients with esophageal carcinoma in an effort to reduce …

… in patients with squamous cell carcinoma of the head and neck survival is impacted by many
factors. These patients often … chemoradiotherapy in patients with Stage III and IV squamous …